Literature DB >> 7678335

Photodynamic inactivation of infectivity of human immunodeficiency virus and other enveloped viruses using hypericin and rose bengal: inhibition of fusion and syncytia formation.

J Lenard1, A Rabson, R Vanderoef.   

Abstract

The mechanism of the antiviral activity of hypericin was characterized and compared with that of rose bengal. Both compounds inactivate enveloped (but not unenveloped) viruses upon illumination by visible light. Human immunodeficiency and vesicular stomatitis viruses were photodynamically inactivated by both dyes at nanomolar concentrations. Photodynamic inactivation of fusion (hemolysis) by vesicular stomatitis, influenza, and Sendai viruses was induced by both dyes under similar conditions (e.g., I50 = 20-50 nM for vesicular stomatitis virus), suggesting that loss of infectivity resulted from inactivation of fusion. Syncytium formation, between cells activated to express human immunodeficiency virus gp120 on their surfaces and CD4+ cells, was inhibited by illumination in the presence of 1 microM hypericin. Hypericin and rose bengal thus exert similar virucidal effects. Both presumably act by the same mechanism--namely, the inactivation of the viral fusion function by singlet oxygen produced upon illumination. The implications of this photodynamic antiviral action for the potential therapeutic usefulness of both hypericin and rose bengal are discussed.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7678335      PMCID: PMC45619          DOI: 10.1073/pnas.90.1.158

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  29 in total

1.  Infection of HTLV-III/LAV in HTLV-I-carrying cells MT-2 and MT-4 and application in a plaque assay.

Authors:  S Harada; Y Koyanagi; N Yamamoto
Journal:  Science       Date:  1985-08-09       Impact factor: 47.728

2.  Photoinactivation of vaccinia virus with rose bengal.

Authors:  G S Turner; C Kaplan
Journal:  J Gen Virol       Date:  1968-12       Impact factor: 3.891

3.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

Review 4.  Hypericin and its photodynamic action.

Authors:  N Durán; P S Song
Journal:  Photochem Photobiol       Date:  1986-06       Impact factor: 3.421

5.  pH-dependent hemolysis by influenza, Semliki, Forest virus, and Sendai virus.

Authors:  J Lenard; D K Miller
Journal:  Virology       Date:  1981-04-30       Impact factor: 3.616

6.  Cell membrane photomodification: relative effectiveness of halogenated fluoresceins for photohemolysis.

Authors:  D P Valenzeno; J P Pooler
Journal:  Photochem Photobiol       Date:  1982-03       Impact factor: 3.421

7.  pH dependence of influenza A virus-induced haemolysis is determined by the haemagglutinin gene.

Authors:  J Lenard; C A Bailey; D K Miller
Journal:  J Gen Virol       Date:  1982-10       Impact factor: 3.891

8.  Effects of DEAE-dextran on infection and hemolysis by VSV. Evidence that nonspecific electrostatic interactions mediate effective binding of VSV to cells.

Authors:  C A Bailey; D K Miller; J Lenard
Journal:  Virology       Date:  1984-02       Impact factor: 3.616

9.  Comparison of the photodynamic action of Rose Bengal and tetrachlorosalicylanilide on isolated porcine erythrocyte membranes.

Authors:  M D Barratt; J C Evans; C A Lewis; C C Rowlands
Journal:  Chem Biol Interact       Date:  1982-01       Impact factor: 5.192

10.  Reconstituted G protein-lipid vesicles from vesicular stomatitis virus and their inhibition of VSV infection.

Authors:  D K Miller; B I Feuer; R Vanderoef; J Lenard
Journal:  J Cell Biol       Date:  1980-02       Impact factor: 10.539

View more
  37 in total

1.  Photodynamic therapy: a new antimicrobial approach to infectious disease?

Authors:  Michael R Hamblin; Tayyaba Hasan
Journal:  Photochem Photobiol Sci       Date:  2004-02-12       Impact factor: 3.982

2.  Dual role of alpha-defensin-1 in anti-HIV-1 innate immunity.

Authors:  Theresa L Chang; Jesus Vargas; Armando DelPortillo; Mary E Klotman
Journal:  J Clin Invest       Date:  2005-03       Impact factor: 14.808

Review 3.  Antiviral therapy for human immunodeficiency virus infections.

Authors:  E De Clercq
Journal:  Clin Microbiol Rev       Date:  1995-04       Impact factor: 26.132

4.  Virucidal agents in the eve of manorapid synergy.

Authors:  Angel S Galabov
Journal:  GMS Krankenhhyg Interdiszip       Date:  2007-09-13

5.  Pharmacokinetics, safety, and antiviral effects of hypericin, a derivative of St. John's wort plant, in patients with chronic hepatitis C virus infection.

Authors:  J M Jacobson; L Feinman; L Liebes; N Ostrow; V Koslowski; A Tobia; B E Cabana; D Lee; J Spritzler; A M Prince
Journal:  Antimicrob Agents Chemother       Date:  2001-02       Impact factor: 5.191

Review 6.  Porphyrin-based cationic amphiphilic photosensitisers as potential anticancer, antimicrobial and immunosuppressive agents.

Authors:  Nela Malatesti; Ivana Munitic; Igor Jurak
Journal:  Biophys Rev       Date:  2017-03-24

7.  Pleomorphic hepatocellular carcinoma following consumption of hypericum perforatum in alcoholic cirrhosis.

Authors:  Evangeli S Lampri; Elli Ioachim; Haralampos Harissis; Eufemia Balasi; Antigoni Mitselou; Vasiliki Malamou-Mitsi
Journal:  World J Gastroenterol       Date:  2014-02-28       Impact factor: 5.742

8.  Wipes coated with a singlet-oxygen-producing photosensitizer are effective against human influenza virus but not against norovirus.

Authors:  Katharina Verhaelen; Martijn Bouwknegt; Saskia Rutjes; Ana Maria de Roda Husman; Erwin Duizer
Journal:  Appl Environ Microbiol       Date:  2014-05-09       Impact factor: 4.792

9.  Anti-influenza virus principles from Muehlenbeckia hastulata.

Authors:  Takaaki Yasuda; Mitsuo Yamaki; Akiko Iimura; Yoshitaka Shimotai; Kazufumi Shimizu; Toshiro Noshita; Shinji Funayama
Journal:  J Nat Med       Date:  2010-04       Impact factor: 2.343

10.  Photoinactivation and kinetics of membrane fusion mediated by the human immunodeficiency virus type 1 envelope glycoprotein.

Authors:  D S Dimitrov; R Blumenthal
Journal:  J Virol       Date:  1994-03       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.